One goal is to develop a fast, non-invasive way to evaluate skin rashes, such as ‘COVID toes’, for ischemia.
The pace of innovation in the ICU is orders of magnitude slower than that of the cath lab and OR, and the COVID-19 crisis has pushed, tested, and exposed ICUs for lacking state-of-the-art technology and resources.
In a Q&A with Zipnosis, Catherine Murphy explains the uptick in telehealth visits and how it is changing the continuum of care.
COVID-19 is driving patients to seek telehealth solutions, and it won’t be a short-term boom.
During an outbreak, it is critical to treat reusable medical devices as potential sources of transmission.
Expanded designs that enable clinicians to leverage data in making healthcare decisions, but privacy challenges remain.
Personalized medicine is the future of healthcare, and artificial intelligence will play a big role.
All of the issues that ECRI calls out on its list are preventable, so device manufacturers and healthcare providers should take serious note.
Device manufacturers must do more to integrate supplier and clinical perspectives during the product design process.
Few things motivate FDA faster than a significant number of adverse events, especially deaths.